Kalaris Therapeutics, Inc. (KLRS) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2025)

-$43.4M

Total Assets (FY2025)

$121.7M

Total Equity (FY2025)

$78.8M

Cash Flows from Operating Activities (FY2025)

-$38.4M

Source: Kalaris Therapeutics, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.